
Buffett Buys Google, Novo Nordisk Cuts Obesity Drug Prices, and Public Launches AI Brokerage
The Rundown
00:00
Novo Nordisk's Challenging Year
Zaid summarizes Novo's downgraded forecasts and the stock's large pullback amid competitive pressures.
Play episode from 04:31
Transcript


